Mankind Pharma surges on incorporating wholly owned subsidiary in Netherlands
Mankind Pharma is currently trading at Rs. 2444.35, up by 26.35 points or 1.09% from its previous closing of Rs. 2418.00 on the BSE.
The scrip opened at Rs. 2417.95 and has touched a high and low of Rs. 2457.00 and Rs. 2415.05 respectively. So far 18782 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2670.00 on 19-Sep-2025 and a 52 week low of Rs. 1909.90 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 2482.15 and Rs. 2383.05 respectively. The current market cap of the company is Rs. 100989.91 crore.
The promoters holding in the company stood at 72.63%, while Institutions and Non-Institutions held 24.80% and 2.57% respectively.
Mankind Pharma has incorporated wholly owned subsidiary (WOS) under the name and style of ‘Mankind Pharma (Netherlands) B.V.’ on August 13, 2026 in the Netherlands. The said WOS has been incorporated to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies.
